Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2012; 18(26): 3426-3434
Published online Jul 14, 2012. doi: 10.3748/wjg.v18.i26.3426
Published online Jul 14, 2012. doi: 10.3748/wjg.v18.i26.3426
Table 4 Adverse reactions to floxuridine n (%)
| Treatment group (toxicity) | NCI-CTC grade | |
| 1-2 | 3-4 | |
| Fever | 2 (5.9) | 0 (0) |
| Nausea/vomiting | 0 (0) | 0 (0) |
| Gastric or duodenal ulcer | 3 (8.8) | 4 (11.8) |
| Mucositis | 4 (11.8) | 3 (8.8) |
| Diarrhea | 4 (11.8) | 3 (8.8) |
| Leukopenia | 2 (5.9) | 1 (2.9) |
| Thrombocytopenia | 2 (5.9) | 1 (2.9) |
| Bilirubin elevation | 4 (11.8) | 1 (2.9) |
| AST/ALT elevation | 5 (14.7) | 1 (2.9) |
| BUN/Cr elevation | 0 (0) | 1 (2.9) |
| Catheter infection | 1 (2.9) | |
| Total | 19 | 9 |
- Citation: Baek YH, Kim KT, Lee SW, Jeong JS, Park BH, Nam KJ, Cho JH, Kim YH, Roh YH, Lee HS, Choi YM, Han SY. Efficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma. World J Gastroenterol 2012; 18(26): 3426-3434
- URL: https://www.wjgnet.com/1007-9327/full/v18/i26/3426.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i26.3426